http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-UB20155616-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44b2d9131286182d91fc94a51ef4930f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | IT-UB20155616-A1 |
titleOfInvention | Process for the preparation of the amorphous form of ibrutinib and new crystalline form. |
priorityDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.